Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.

Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.

Mutations in the glucokinase (GK) gene cause defects in blood glucose homeostasis. In some cases (V62M and G72R), the phenotype cannot be explained by altered enzyme kinetics or protein instability. We used transient and stable expression of green fluorescent protein (GFP) GK chimaeras in MIN6 beta-...

Detaylı Bibliyografya
Asıl Yazarlar:	Arden, C, Trainer, A, de la Iglesia, N, Scougall, K, Gloyn, A, Lange, A, Shaw, J, Matschinsky, F, Agius, L
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

Catalytic instability of the glucokinase MODY-2 mutants V62M and G72R in pancreatic beta cells
Yazar:: Arden, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
Yazar:: Gasperikova, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
Yazar:: Rees, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

NGF effects promote the maturation of rat pancreatic beta cells by regulating GLUT2 levels and distribution, and glucokinase activity.
Yazar:: Jazmín Samario-Román, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Yazar:: Gloyn, A
Baskı/Yayın Bilgisi: (2003)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Yazar:: Ding, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
Yazar:: Rees, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
Yazar:: Rees, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
Yazar:: Beer, N, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

α-cell glucokinase suppresses glucose-regulated glucagon secretion
Yazar:: Basco, D, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
Yazar:: Tribble, N, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
Yazar:: Matthew G Rees, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Association of glucokinase, glucokinase regulator, glucose-6-phosphatase catalytic subunit 2 and melatonin receptor 1b genes polymorphisms with type 2 diabetic subjects
Yazar:: Ansari, Neda
Baskı/Yayın Bilgisi: (2020)

Meaux (Seine-et-Marne). 62-72, rue Saint-Faron
Yazar:: David Couturier
Baskı/Yayın Bilgisi: (2004-10-01)

Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Yazar:: Flanagan, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
Yazar:: Beer, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans.
Yazar:: van de Bunt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Persistent hyperinsulinemic hypoglycemia in a 7 yr old girl due to a novel activating glucokinase mutation
Yazar:: Lahr, G, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
Yazar:: Valentinova, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Screening for mutations in the Kir6.2 subunit of the beta-cell K-ATP channel
Yazar:: Sakura, H, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Yazar:: Hansen, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Familial persistent hyperinsulinaemic hypoglycaemia of infancy due to a novel glucokinase (GCK) activating mutation G68V
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.
Yazar:: Gloyn, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA4
Yazar:: Nanda Kumar Yellapu, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
Yazar:: Thomson, K, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Yazar:: Valentinova, L, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Insights into glucokinase regulatory protein regulation from the cellular and kinetic characterisation of rare coding variants
Yazar:: Rees, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
Yazar:: Beer, N, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.
Yazar:: Girard, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
Yazar:: Beer, N, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Yazar:: Osbak, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
Yazar:: Turkkahraman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)